BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6806486)

  • 1. Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.
    Paulson DF; Cline WA; Koefoot RB; Hinshaw W; Stephani S
    J Urol; 1982 May; 127(5):935-7. PubMed ID: 6806486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate.
    Paulson DF; Hodge GB; Hinshaw W
    J Urol; 1984 May; 131(5):901-2. PubMed ID: 6423840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of patients with stage D1 prostatic adenocarcinoma.
    Kramer SA; Cline WA; Farnham R; Carson CC; Cox EB; Hinshaw W; Paulson DF
    J Urol; 1981 Jun; 125(6):817-9. PubMed ID: 7241680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study.
    Zagars GK; Johnson DE; von Eschenbach AC; Hussey DH
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1085-91. PubMed ID: 3133327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Carcinoma-therapeutic considerations in the management of gross lymph node metastases.
    Green N; Broth E; George FW; Goldstein A; Melbye RW; Morrow J; Onofrio R; Polse S; Skaist L
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):891-7. PubMed ID: 115816
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
    Lawton CA; Winter K; Grignon D; Pilepich MV
    J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 8. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy.
    Buskirk SJ; Pisansky TM; Atkinson EJ; Schild SE; O'Brien PC; Wolfe JT; Zincke H
    Mayo Clin Proc; 2001 Jul; 76(7):702-6. PubMed ID: 11444402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapy: the benefits of postponed initiation.
    Cockburn AG
    Urology; 1984 Nov; 24(5 Suppl):24-6. PubMed ID: 6388093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327).
    Camuzzi F; Block NL; Stover B; Gottlieb C; Charyulu K; Politano VA
    Urology; 1980 May; 15(5):443-7. PubMed ID: 7052707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience in the treatment of localized carcinoma of the prostate by definitive external irradiation.
    Kuten A; Nitetzky S; Tatcher M; Cohen Y; Robinson E
    Int Urol Nephrol; 1989; 21(3):325-32. PubMed ID: 2509392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the prostate: treatment with external radiotherapy.
    Harisiadis L; Veenema RJ; Senyszyn JJ; Puchner PJ; Tretter P; Romas NA; Chang CH; Lattimer JK; Tannenbaum M
    Cancer; 1978 Jun; 41(6):2131-42. PubMed ID: 657085
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of radiation therapy in the definitive treatment of adenocarcinoma of the prostate.
    Ray GR; Bagshaw MA
    Annu Rev Med; 1975; 26():567-88. PubMed ID: 807150
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer: experience with definitive irradiation in the aged.
    Green N; Bodner H; Broth E
    Urology; 1985 Mar; 25(3):228-32. PubMed ID: 2579498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
    Isaacs JT
    Cancer Res; 1982 Dec; 42(12):5010-4. PubMed ID: 6215981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of clinical local failure after radiation therapy for prostate carcinoma.
    Schellhammer PF; Kuban DA; el-Mahdi AM
    J Urol; 1993 Dec; 150(6):1851-5. PubMed ID: 8230518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic cancer revisited.
    Cosgrove MD; Kaempf MJ
    J Urol; 1976 Jan; 115(1):79-81. PubMed ID: 813018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
    Zincke H; Utz DC; Taylor WF
    J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate.
    Smith JA; Haynes TH; Middleton RG
    J Urol; 1984 Apr; 131(4):705-7. PubMed ID: 6708186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.